We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Advances While Market Declines: Some Information for Investors
Read MoreHide Full Article
UnitedHealth Group (UNH - Free Report) closed the most recent trading day at $307.70, moving +1.31% from the previous trading session. This change outpaced the S&P 500's 0.07% loss on the day. At the same time, the Dow lost 0.37%, and the tech-heavy Nasdaq gained 0.03%.
Shares of the largest U.S. health insurer have appreciated by 0.17% over the course of the past month, outperforming the Medical sector's loss of 1.3%, and lagging the S&P 500's gain of 3.94%.
Analysts and investors alike will be keeping a close eye on the performance of UnitedHealth Group in its upcoming earnings disclosure. The company's earnings report is set to go public on July 29, 2025. In that report, analysts expect UnitedHealth Group to post earnings of $5.08 per share. This would mark a year-over-year decline of 25.29%. In the meantime, our current consensus estimate forecasts the revenue to be $111.86 billion, indicating a 13.16% growth compared to the corresponding quarter of the prior year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $21.85 per share and a revenue of $449.46 billion, signifying shifts of -21.01% and +12.29%, respectively, from the last year.
It's also important for investors to be aware of any recent modifications to analyst estimates for UnitedHealth Group. These recent revisions tend to reflect the evolving nature of short-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 2.81% lower. UnitedHealth Group currently has a Zacks Rank of #5 (Strong Sell).
In terms of valuation, UnitedHealth Group is presently being traded at a Forward P/E ratio of 13.9. This valuation marks a premium compared to its industry average Forward P/E of 13.02.
It is also worth noting that UNH currently has a PEG ratio of 1.45. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical - HMOs industry currently had an average PEG ratio of 0.86 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 91, which puts it in the top 37% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth Group (UNH) Advances While Market Declines: Some Information for Investors
UnitedHealth Group (UNH - Free Report) closed the most recent trading day at $307.70, moving +1.31% from the previous trading session. This change outpaced the S&P 500's 0.07% loss on the day. At the same time, the Dow lost 0.37%, and the tech-heavy Nasdaq gained 0.03%.
Shares of the largest U.S. health insurer have appreciated by 0.17% over the course of the past month, outperforming the Medical sector's loss of 1.3%, and lagging the S&P 500's gain of 3.94%.
Analysts and investors alike will be keeping a close eye on the performance of UnitedHealth Group in its upcoming earnings disclosure. The company's earnings report is set to go public on July 29, 2025. In that report, analysts expect UnitedHealth Group to post earnings of $5.08 per share. This would mark a year-over-year decline of 25.29%. In the meantime, our current consensus estimate forecasts the revenue to be $111.86 billion, indicating a 13.16% growth compared to the corresponding quarter of the prior year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $21.85 per share and a revenue of $449.46 billion, signifying shifts of -21.01% and +12.29%, respectively, from the last year.
It's also important for investors to be aware of any recent modifications to analyst estimates for UnitedHealth Group. These recent revisions tend to reflect the evolving nature of short-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 2.81% lower. UnitedHealth Group currently has a Zacks Rank of #5 (Strong Sell).
In terms of valuation, UnitedHealth Group is presently being traded at a Forward P/E ratio of 13.9. This valuation marks a premium compared to its industry average Forward P/E of 13.02.
It is also worth noting that UNH currently has a PEG ratio of 1.45. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical - HMOs industry currently had an average PEG ratio of 0.86 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 91, which puts it in the top 37% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.